Loginova, E. Y., Korotaeva, T. V., Gubar, E. E., Korsakova, Y. L., Sedunova, M. V., Pristavskiy, I. N., . . . Nasonov, E. L. Influence of the duration of psoriatic arthritis on the achievement of remission and minimal disease activity during therapy with genetically engineered biologic drugs. Data from the all-russian register of patients with psoriatic arthritis. IMA PRESS LLC.
Chicago Style (17th ed.) CitationLoginova, E. Yu., et al. Influence of the Duration of Psoriatic Arthritis on the Achievement of Remission and Minimal Disease Activity During Therapy with Genetically Engineered Biologic Drugs. Data from the All-russian Register of Patients with Psoriatic Arthritis. IMA PRESS LLC.
MLA (9th ed.) CitationLoginova, E. Yu., et al. Influence of the Duration of Psoriatic Arthritis on the Achievement of Remission and Minimal Disease Activity During Therapy with Genetically Engineered Biologic Drugs. Data from the All-russian Register of Patients with Psoriatic Arthritis. IMA PRESS LLC.